Literature DB >> 15583264

Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Atsuko Kodama1, Kazunari Kamachi, Yoshinobu Horiuchi, Toshifumi Konda, Yoshichika Arakawa.   

Abstract

Antigenic divergence has been found between Bordetella pertussis vaccine strains and circulating strains in several countries. In the present study, we analyzed B. pertussis isolates collected in Japan from 1988 to 2001 using pulsed-field gel electrophoresis (PFGE) and sequencing of two virulence-associated proteins. The 107 isolates were classified into three major groups by PFGE analysis; 87 (81%) were type A, 19 (18%) were type B, and 1 (1%) was type C. Sequence analysis of the S1 subunit of pertussis toxin (ptxS1) and adhesion pertactin (prn) genes revealed the presence of two (ptxS1A and ptxS1B) and three (prn1, prn2, and prn3) variants, respectively, in the isolates. Among those isolates, 82 (95%) of the 87 type A strains and the type C strain had the same combination of ptxS1B and prn1 alleles (ptxS1B/prn1) as the Japanese vaccine strain. On the other hand, 17 (90%) of 19 type B strains had an allele (ptxS1A/prn2) distinct from that of the vaccine strain. A correlation was found between the antigenic variation and the PFGE profile in the isolates. In addition, the frequency of the type B strain was 0, 27, 0, 42, and 37% of the isolates in the periods 1988 to 1993, 1994 to 1995, 1996 to 1997, 1998 to 1999, and 2000 to 2001, respectively. In contrast, the number of reported pertussis-like and pertussis cases decreased gradually from 1991 on, suggesting that the antigenic divergence did not affect the efficacy of pertussis vaccination in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583264      PMCID: PMC535240          DOI: 10.1128/JCM.42.12.5453-5457.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

2.  Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.

Authors:  P Cassiday; G Sanden; K Heuvelman; F Mooi; K M Bisgard; T Popovic
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.

Authors:  A Gzyl; E Augustynowicz; I van Loo; J Slusarczyk
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

5.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.

Authors:  N Guiso; C Boursaux-Eude; C Weber; S Z Hausman; H Sato; M Iwaki; K Kamachi; T Konda; D L Burns
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

7.  Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.

Authors:  D Güriş; P M Strebel; B Bardenheier; M Brennan; R Tachdjian; E Finch; M Wharton; J R Livengood
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

8.  Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity.

Authors:  A J King; G Berbers; H F van Oirschot; P Hoogerhout; K Knipping; F R Mooi
Journal:  Microbiology       Date:  2001-11       Impact factor: 2.777

9.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Authors:  H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

10.  Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999.

Authors:  Terri Hawes Hardwick; Pamela Cassiday; Robbin S Weyant; Kristine M Bisgard; Gary N Sanden
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  14 in total

1.  Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Authors:  Shu-Man Yao; Yu-Chi Lin; Chen-Ying Chou; Ying-Yan Chen; Miao-Ju Hsiao; Hour-Young Chen; Jer-Jea Yan; Hsun-Pi Su; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.

Authors:  Hans Hallander; Abdolreza Advani; Marion Riffelmann; Carl H W von König; Valerie Caro; Nicole Guiso; Frits R Mooi; Anna Gzyl; Margit S Kaltoft; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

3.  Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis.

Authors:  Jacob Kurniawan; Ram P Maharjan; Wai Fong Chan; Peter R Reeves; Vitali Sintchenko; Gwendolyn L Gilbert; Frits R Mooi; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

4.  Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.

Authors:  Hyun-Ja Han; Asaomi Kuwae; Akio Abe; Yoshichika Arakawa; Kazunari Kamachi
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

5.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

6.  SNP-based typing: a useful tool to study Bordetella pertussis populations.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Teemu Kallonen; Qiushui He; Jussi Mertsola; Abdolreza Advani; Hans O Hallander; Koen Janssens; Peter W Hermans; Frits R Mooi
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

7.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

Review 8.  Perplexities of pertussis: recent global epidemiological trends and their potential causes.

Authors:  D W Jackson; Pejman Rohani
Journal:  Epidemiol Infect       Date:  2013-01-16       Impact factor: 4.434

9.  Population diversity among Bordetella pertussis isolates, United States, 1935-2009.

Authors:  Amber J Schmidtke; Kathryn O Boney; Stacey W Martin; Tami H Skoff; M Lucia Tondella; Kathleen M Tatti
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

10.  Effect of vaccination on Bordetella pertussis strains, China.

Authors:  Liu Zhang; Yinghua Xu; Jianhong Zhao; Teemu Kallonen; Shenghui Cui; Yunqiang Xu; Qiming Hou; Fengxiang Li; Junzhi Wang; Qiushui He; Shumin Zhang
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.